Note 14 - Segment Information

12 Months Ended

Jun. 30, 2015

Notes to Financial Statements

Segment Reporting Disclosure [Text Block]

Note 1

4

.

Segment Information

The basis for presenting segment results generally is consistent with overall Company reporting. The Company reports information about its operating segments in accordance with GAAP which establishes standards for reporting information about a company’s operating segments.

The Company has divided its operations into three reportable segments as follows: Contract Manufacturing, Branded Proprietary Products and Other Nutraceutical Businesses. The international sales, concentrated primarily in Europe and Canada, for the fiscal years ended June 30, 2015 and 2014 were $8,497 and $10,970, respectively.

Financial information relating to the fiscal years ended June 30, 2015 and 2014 operations by business segment are as follows:

		Sales, Net						Segment
		U.S.		International				Gross					Capital		Total
		Customers		Customers		Total		Profit (Loss)			Depreciation		Expenditures		Assets
Contract	2015	$	26,779	$	7,478	$	34,257	$	3,673		$	265	$	421	$	8,482
Manufacturing	2014		20,096		9,970		30,066		4,209			241		255		7,752
Branded	2015		299		859		1,158		(42	)		1		1		1,324
Proprietary Products	2014		501		847		1,348		86			2		1		1,781
Other Nutraceutical	2015		1,913		160		2,073		762			2		-		1,817
Businesses	2014		2,116		153		2,269		588			9		2		2,050
Total Company	2015		28,991		8,497		37,488		4,393			268		422		11,623
	2014		22,713		10,970		33,683		4,883			252		258		11,583